From the Journals

Study shows that 20% of inpatients given antibiotics develop adverse reactions


 

FROM JAMA INTERNAL MEDICINE

Twenty percent of hospitalized adults given antibiotics develop adverse drug events, including GI, nephrotoxic, hematologic, cardiac, and neurotoxic effects, according to a report in JAMA Internal Medicine.

This high frequency of adverse reactions “may not be recognized by clinicians because [these events] have varied manifestations, clinicians may be unaware of the risks associated with specific antibiotic agents, or because they occur after patients are discharged from the hospital,” said Pranita D. Tamma, MD, of the division of pediatric infectious diseases, Johns Hopkins University, Baltimore, and her associates.

They assessed antibiotic-associated adverse drug events in all 1,488 adults admitted to four general medicine services at a single medical center during a 9-month period and given at least 24 hours of any antibiotic therapy. The most common indications for antibiotics were urinary tract infections (12%), skin and soft-tissue infections (8%), and community-acquired pneumonia (7%).

oksix/Thinkstock
A total of 298 patients (20%) developed at least one adverse reaction to an antibiotic, and there were 324 unique adverse events. Most of these (73%) developed during hospitalization, but a significant portion (27%) occurred after discharge. Almost all were considered clinically significant because they required prolonged hospitalization; a subsequent hospitalization; an ED visit; or additional lab tests, ECGs, or imaging studies.

Perhaps as important, the researchers noted, 19% of these adverse drug events were attributed to unnecessary antibiotics – drugs given for conditions for which they were not clinically indicated according to the hospital’s own antibiotic guidelines. These included asymptomatic bacteriuria, aspiration pneumonitis, and heart failure (JAMA Intern. Med. 2017 June 12. doi: 10.1001/jamainternmed.2017.1938).

The most common adverse reactions that developed within 30 days were GI, renal, and hematologic abnormalities. Neurotoxic effects included encephalopathy and seizures; cardiotoxic effects included QTc prolongation. Less frequent adverse events included anaphylaxis, daptomycin-associated myositis, trimethoprim/sulfamethoxazole-associated pancreatitis, linezolid-associated neuropathy, and ciprofloxacin-related tendinitis. The most common adverse reactions that developed within 90 days were C. difficile infections and infections involving multidrug-resistant organisms.

“Our findings underscore the importance of avoiding unnecessary antibiotic prescribing to reduce the harm that can result from antibiotic-associated adverse drug events,” Dr. Tamma and her associates said.

Recommended Reading

Infectious disease physicians: Antibiotic shortages are the new norm
MDedge Pediatrics
Rate of resistant P. aeruginosa in children rising steadily
MDedge Pediatrics
Antibiotic resistance remains a challenge for hospitals
MDedge Pediatrics
Shorter-course antimicrobials do not reduce antimicrobial resistance in AOM
MDedge Pediatrics
When to discontinue contact precautions for patients with MRSA
MDedge Pediatrics
CDC: Some Shigella strains show reduced ciprofloxacin susceptibility
MDedge Pediatrics
Each added day of pediatric MRSA bacteremia upped complication risk 50%
MDedge Pediatrics
VIDEO: Registry study will follow 4,000 fecal transplant patients for 10 years
MDedge Pediatrics
Molecular tests for GAS pharyngitis could spur overuse of antibiotics
MDedge Pediatrics
E. coli, GBS account for majority of neonatal bacterial meningitis in Canada
MDedge Pediatrics